JP2006521088A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006521088A5 JP2006521088A5 JP2004570301A JP2004570301A JP2006521088A5 JP 2006521088 A5 JP2006521088 A5 JP 2006521088A5 JP 2004570301 A JP2004570301 A JP 2004570301A JP 2004570301 A JP2004570301 A JP 2004570301A JP 2006521088 A5 JP2006521088 A5 JP 2006521088A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- sequence
- antibody
- variable domain
- domain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0226723A GB0226723D0 (en) | 2002-11-15 | 2002-11-15 | Antibodies for in vitro use |
| GBGB0226729.2A GB0226729D0 (en) | 2002-11-15 | 2002-11-15 | Intracellular antibodies |
| GB0226728A GB0226728D0 (en) | 2002-11-15 | 2002-11-15 | Anti-activated RAS antibodies |
| GBGB0226727.6A GB0226727D0 (en) | 2002-11-15 | 2002-11-15 | Intrabodies |
| GB0226731A GB0226731D0 (en) | 2002-11-15 | 2002-11-15 | Method for generating immunoglobulin genes |
| GB0316680A GB0316680D0 (en) | 2003-07-16 | 2003-07-16 | Anti-activated RAS antibodies |
| PCT/GB2003/004953 WO2004046188A2 (en) | 2002-11-15 | 2003-11-14 | Anti-activated ras antibodies |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006521088A JP2006521088A (ja) | 2006-09-21 |
| JP2006521088A5 true JP2006521088A5 (cg-RX-API-DMAC10.html) | 2006-11-30 |
Family
ID=32330172
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004570301A Withdrawn JP2006521088A (ja) | 2002-11-15 | 2003-11-14 | 抗活性化ｒａｓ抗体 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20050288492A1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP1565495A2 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2006521088A (cg-RX-API-DMAC10.html) |
| AU (1) | AU2003282247A1 (cg-RX-API-DMAC10.html) |
| CA (1) | CA2506128A1 (cg-RX-API-DMAC10.html) |
| WO (1) | WO2004046188A2 (cg-RX-API-DMAC10.html) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT2360255E (pt) | 2005-03-25 | 2015-04-08 | Nat Res Council Canada | Método para isolamento de polipéptidos solúveis |
| EP1867661A1 (en) * | 2006-06-12 | 2007-12-19 | Diatos | Compositions and methods for delivering anti-activated ras antibodies into cells |
| JP5172943B2 (ja) | 2008-03-12 | 2013-03-27 | パナソニック株式会社 | 無線通信装置、無線通信システム及び無線通信方法 |
| AU2010238346A1 (en) * | 2009-04-14 | 2011-11-03 | Trojan Technologies Ltd. | Therapeutic Antennapedia-antibody molecules and methods of use thereof |
| GB201103631D0 (en) * | 2011-03-03 | 2011-04-13 | Univ Leeds | Identification of candidate therapeutics |
| HRP20201914T1 (hr) | 2013-05-06 | 2021-01-22 | Scholar Rock, Inc. | Sastavi i postupci za modulaciju faktora rasta |
| KR101602876B1 (ko) | 2014-07-22 | 2016-03-11 | 아주대학교산학협력단 | 완전한 이뮤노글로불린 형태의 세포질 침투능을 갖는 항체를 이용하여 세포내 활성화된 ras를 억제하는 방법 및 그의 이용 |
| KR101602870B1 (ko) | 2014-07-22 | 2016-03-21 | 아주대학교산학협력단 | 완전한 이뮤노글로불린 형태의 항체를 세포막을 투과하여 세포질에 위치시키는 방법 및 그의 이용 |
| WO2016013871A1 (ko) * | 2014-07-22 | 2016-01-28 | 아주대학교산학협력단 | 완전한 이뮤노글로불린 형태의 세포질 침투능을 갖는 항체를 이용하여 세포내 활성화된 ras를 억제하는 방법 및 그의 이용 |
| MX2017006167A (es) | 2014-11-12 | 2018-03-23 | Siamab Therapeutics Inc | Compuestos que interactúan con glicanos y métodos de uso. |
| CA3002097A1 (en) | 2015-11-12 | 2017-05-18 | Siamab Therapeutics, Inc. | Glycan-interacting compounds and methods of use |
| JP2019520086A (ja) | 2016-05-27 | 2019-07-18 | オラム・セラピューティクス・インコーポレイテッド | 細胞質浸透抗体およびその用途 |
| WO2018094143A1 (en) | 2016-11-17 | 2018-05-24 | Siamab Therapeutics, Inc. | Glycan-interacting compounds and methods of use |
| KR20240044544A (ko) | 2017-03-03 | 2024-04-04 | 씨젠 인크. | 글리칸-상호작용 화합물 및 사용 방법 |
| WO2019014190A1 (en) | 2017-07-10 | 2019-01-17 | Brown Kathlynn C | MOLECULAR GUIDANCE SYSTEM PEPTIDES AND USES THEREOF |
| EP3652195A4 (en) | 2017-07-10 | 2021-08-04 | SRI International | PEPTID-SAPORINE CONJUGATE FOR THE TREATMENT OF CANCER |
| KR20190143826A (ko) | 2018-06-21 | 2019-12-31 | 오름테라퓨틱 주식회사 | 세포/조직 특이적 세포 침투 항체 |
| GB202006974D0 (en) * | 2020-05-12 | 2020-06-24 | Univ Oxford Innovation Ltd | Chimaeric proteins and therapeutic agents |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2003219277A1 (en) * | 2002-03-14 | 2003-09-29 | Medical Research Council | Intracellular antibodies |
-
2003
- 2003-11-14 EP EP03773865A patent/EP1565495A2/en not_active Withdrawn
- 2003-11-14 JP JP2004570301A patent/JP2006521088A/ja not_active Withdrawn
- 2003-11-14 WO PCT/GB2003/004953 patent/WO2004046188A2/en not_active Ceased
- 2003-11-14 AU AU2003282247A patent/AU2003282247A1/en not_active Abandoned
- 2003-11-14 CA CA002506128A patent/CA2506128A1/en not_active Abandoned
-
2005
- 2005-05-12 US US11/127,903 patent/US20050288492A1/en not_active Abandoned